<rss version="2.0" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
<channel>
	<generator>Vivvo CMS 4.1</generator>
	<title>PRI: Public Radio International</title>
	<link>http://www.pri.org/</link>
	<copyright>&amp;copy;2010 Spoonlabs d.o.o.</copyright>
	<image>
		<title>PRI: Public Radio International</title>
		<url>http://www.pri.org/files.php?file=rss_682409203.gif</url>
		<link>http://www.pri.org/</link>
	</image>
	
			
				
					<item>
						
							<title>FDA panel recommends approval of anti-obesity drug</title>
							<link>http://www.pri.org/stories/health/fda-panel-recommends-approval-of-anti-obesity-drug-8624.html</link>
							<category>Health and Medicine</category>
							<pubDate>Fri, 24 Feb 2012 13:00:00 -0600</pubDate>
							<description>An advisory panel of outside physicians for the FDA recommended approval of the weight-loss drug Qnexa, which was previously rejected in 2010. Pending approval, Qnexa could be the most effective non-surgery treatment for obese people. The FDA will make a final decision later this year.</description>
							
						
					</item>
					
							
						
				
			
		




<description>PRI: Public Radio International</description>
</channel>
</rss>